Bottom line
Is MCOW a good fund? The bottom line
MCOW is an index mid-cap ETF from Pacer.
Annual fees run 0.49% — about $49 a year on every $10,000 invested, cheaper than 86% of mid-cap funds we track.
With $1.1 million in net assets and 78 holdings, its largest position is Everpure Inc (4.9%) and the top 10 make up 32.5% of the portfolio.
What stands out
- Low cost: cheaper than 86% of mid-cap peers
What to watch
- Small fund ($1.1 million) — small funds are likelier to close
Updated Nov 19, 2026
What MCOW invests in
The Pacer S&P MidCap 400 Quality FCF Aristocrats ETF (the Fund) is an exchange traded fund (ETF) that seeks to track the total return performance, before fees and expenses, of the S&P MidCap 400 Quality FCF Aristocrats Index (the Index).
The Fund employs a rules-based, passive management (or indexing) investment approach designed to track the total return performance, before fees and expenses, of the Index. The Index S&P Dow Jones Indices LLC (the Index Provider) compiles, maintains and calculates the Index, which measures the performance of companies within the S&P MidCap 400 Index (the S&P MidCap 400) that have had positive free cash flow (FCF) for at least seven consecutive years and simultaneously have high FCF margin and high FCF return on invested capital (ROIC) relative to the other companies in the S&P MidCap 400. The initial Index universe is derived from the component companies of the S&P MidCap 400 Index. The S&P MidCap 400 is comprised of common stocks of approximately 400 mid-capitalization companies that generally represent the mid-cap segment of the U.S. equity market. Free Cash Flow (FCF): net cash flow…
From the fund's prospectus (filed Feb 27, 2026).
What MCOW costs
On a $10,000 investment, MCOW's 0.49% expense ratio costs about $49 a year. The median mid-cap fund charges 0.88%.
MCOW top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Everpure Inc P | 4.91% |
| 2 | Manhattan Associates Inc MANH | 3.65% |
| 3 | Lattice Semiconductor Corp LSCC | 3.62% |
| 4 | Docusign Inc DOCU | 3.60% |
| 5 | Medpace Holdings Inc MEDP | 3.58% |
| 6 | Sterling Infrastructure Inc STRL | 3.03% |
| 7 | Exelixis Inc EXEL | 2.67% |
| 8 | Neurocrine Biosciences Inc NBIX | 2.57% |
| 9 | Jazz Pharmaceuticals PLC JAZZ | 2.52% |
| 10 | Mueller Industries Inc MLI | 2.32% |
Source: SEC Form N-PORT, period ended Jul 31, 2026
The top 10 make up 32.5% of the fund. See all top 25 holdings and asset mix →